Another Three Products are Approved by US FDA

One oral contraceptive product (Malmorede™) and two extended-release products (Metoprolol Succinate ER Tablets and Metformin Hydrochloride ER Tablets), both developed by NOVAST, receive approval from the US FDA in 2018.